Product Information
ATROPINE 1% EYE DROPS is a generic product labeled by NorthStar Rx LLC, priced at $11.5149 per ML under NDC 72603026401. Its NADAC has been published 88 times since Jan 29, 2025.
FDA first approved this application on Jan 8, 2024. Its Orange Book therapeutic-equivalence code is AT1.
Strength
10 mg/mL
Manufacturer
NorthStar Rx LLCNDC
72603026401
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
ATROPINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA218148FDA Approved
1/8/2024
TE Code
AT1
On Market Since
9/1/2024
Pharmacological Classes
Price Statistics
The NADAC for ATROPINE 1% EYE DROPS has been published 88 times since Jan 29, 2025, and over the history we have for it it has declined 15.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.5149 per ML |
|---|---|
| All-time high | $13.5666 (Feb 12, 2025) |
| All-time low | $11.5149 (Sep 23, 2026) |
| 52-week high | $13.3034 |
| 52-week low | $11.5149 |
| Median price | $12.8407 |
| Average price | $12.7773 |
| Largest weekly change | -10.6% (Sep 23, 2026) |
| Weeks tracked | 88 |
| Tracking since | Jan 29, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Atropine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATROPINE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ATROPINE 1% EYE DROPS, manufactured by NorthStar Rx LLC, is $11.5149 per ML (NDC 72603026401), effective Sep 30, 2026.
How has the price of ATROPINE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for ATROPINE 1% EYE DROPS has declined 15.1%. It has been tracked across 88 weekly CMS publications since Jan 29, 2025.
What are the highest and lowest recorded NADAC prices for ATROPINE 1% EYE DROPS?
Since Jan 29, 2025, the NADAC for ATROPINE 1% EYE DROPS has ranged from a low of $11.5149 (Sep 23, 2026) to a high of $13.5666 (Feb 12, 2025), with a median of $12.8407 per ML.
Are there cheaper alternatives to ATROPINE 1% EYE DROPS?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATROPINE 1% EYE DROPS, is $4.1619 per ML — about 64% below ATROPINE 1% EYE DROPS.
Who manufactures ATROPINE 1% EYE DROPS?
ATROPINE 1% EYE DROPS (NDC 72603026401) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.